Skip to main content

Table 2 Distribution of urinary phthalate metabolitesa (n = 415)

From: Urinary phthalate metabolites in relation to serum anti-Müllerian hormone and inhibin B levels among women from a fertility center: a retrospective analysis

Metabolites

% > LOD

GM

Median

Selected percentiles

25%

75%

MMP

96.6

7.23

6.86

3.65

15.86

MEP

100

10.73

8.81

4.16

22.28

MBP

100

106.40

112.74

66.61

180.82

MBzP

95.4

0.08

0.07

0.03

0.17

MEHP

98.8

9.99

10.75

5.44

20.68

MEHHP

100

13.40

12.30

8.16

20.46

MEOHP

100

10.42

10.27

6.36

16.91

MOP

28.7

0.04

<LOD

<LOD

0.12

∑DEHP

0.13

0.12

0.08

0.20

  1. LOD: the limits of detection; GM: geometric mean; MMP: monomethyl phthalate; MEP: monoethyl phthalate; MBP: monobutyl phthalate; MBzP: monobenzyl phthalate; MEHP: mono(2-ethylhexyl) phthalate; MEHHP: mono(2-ethyl-5-hydroxyhexyl) phthalate; MEOHP: mono(2-ethyl-5-oxohexyl) phthalate; MOP: mono-n-octyl phthalate; DEHP: di(2-ethylhexyl) phthalate
  2. ∑DEHP: Molar sum of DEHP metabolites (MEHP, MEHHP and MEOHP) expressed in μmol/g creatinine (Cr)
  3. % > LOD: Phthalate metabolites above the limits of detection
  4. aUrinary phthalate metabolites concentrations were creatinine adjusted (μg/g Cr)